Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.65 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13264390 | 0.84 | ALDH1A1 (0.61) | TDP1L3MBTL1CTDSP1ALDH1A1MAPK1 | |
| SCHEMBL14470793 | 0.83 | ALDH1A1 (0.55) | TDP1L3MBTL1CTDSP1ALDH1A1MAPK1 | |
| SCHEMBL27541871 | 0.83 | ALDH1A1 (0.55) | TDP1L3MBTL1CTDSP1ALDH1A1MAPK1 | |
| SCHEMBL14280016 | 0.83 | TDP1 (0.66) | TDP1L3MBTL1CTDSP1ALDH1A1MAPK1 | |
| SCHEMBL1640414 | 0.79 | TDP1 (0.68) | TDP1L3MBTL1CTDSP1ALDH1A1MAPK1 | |
| SCHEMBL8923884 | 0.78 | TDP1 (0.62) | TDP1L3MBTL1CTDSP1ALDH1A1MAPK1 | |
| SCHEMBL27939896 | 0.77 | TDP1 (0.58) | TDP1L3MBTL1ALDH1A1MAPK1LMNA | |
| SCHEMBL179961 | 0.77 | ALDH1A1 (0.64) | TDP1ALDH1A1MAPK1KDM4ERAB9A | |
| SCHEMBL10036470 | 0.77 | TDP1 (0.66) | TDP1L3MBTL1CTDSP1ALDH1A1MAPK1 | |
| SCHEMBL361245 | 0.77 | DAO (0.58) | TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3104835-B1 | PULVURENT EFFERVESCENT TOPICAL TREATMENT COMPOSITION | RECKITT BENCKISER LLC (US) | 2019-02-13 | — | — | EP | disclosed |
| US-9877484-B2 | Pulvurent effervescent topical treatment composition | RECKITT BENCKISER LLC (US) | 2018-01-30 | — | — | US | disclosed |
| US-20170006874-A1 | PULVURENT EFFERVESCENT TOPICAL TREATMENT COMPOSITION | RECKITT BENCKISER LLC (US) | 2017-01-12 | — | — | US | disclosed |
| EP-3104835-A1 | PULVURENT EFFERVESCENT TOPICAL TREATMENT COMPOSITION | Reckitt Benckiser LLC (US) | 2016-12-21 | — | — | EP | disclosed |
| WO-2015121659-A1 | PULVURENT EFFERVESCENT TOPICAL TREATMENT COMPOSITION | RECKITT BENCKISER LLC (US) | 2015-08-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170006874-A1 | PULVURENT EFFERVESCENT TOPICAL TREATMENT COMPOSITION | SOST, FPR2, SHH | TDP1 4572/4885L3MBTL1 3586/4885CTDSP1 2418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.